Last reviewed · How we verify
NCT03251781
Minimal Important Difference for the Glittre-ADL Test and London Chest Activity of Daily Living Scale
NA trial testing Pulmonary Rehabilitation in Pulmonary Disease, Chronic Obstructive in 77 participants. Completed in 30 November 2017.
31 May 2017
Quick facts
| Lead sponsor | University of the State of Santa Catarina |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 77 |
| Start date | 1 April 2013 |
| Primary completion | 31 May 2017 |
| Estimated completion | 30 November 2017 |
| Sites | 2 locations across Brazil |
Drugs / interventions tested
- Pulmonary Rehabilitation
Conditions studied
- Pulmonary Disease, Chronic Obstructive — all drugs for Pulmonary Disease, Chronic Obstructive →
Sponsor
University of the State of Santa Catarina
Who can join
Adults 40 to 80, any sex, with Pulmonary Disease, Chronic Obstructive. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: The ability to perform activities of daily living (ADL) in patients with chronic obstructive pulmonary disease is often impaired. Glittre-ADL Test has been used to assess limitations in ADL, and it seems to be responsive to intervention. However, the minimal detectable change for Glittre-ADL Test remains unknown. Design: Non-controlled before and after study. Setting: The study will be conducted in an outpatient pulmonary rehabilitation program in Florianopolis, Brazil. Subjects: Patients with COPD (GOLD II-IV). Interventions: Pulmonary rehabilitation program based on physical training, conducted over 24 sessions supervised, three times a week, including aerobic training in treadmill and localized training for upper limbs and lower limbs. Main measures: Glittre ADL-Test performance, six-minute walk test performance, London Chest Activity of Daily Living score, Modified Medical Research Council score, COPD Assessment Test score, Saint George Respiratory Questionnaire score before and after the pulmonary rehabilitation program.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Minimal important difference for London Chest Activity of Daily Living scale in patients with chronic obstructive pulmonary disease.
Almeida Gulart A, de Araujo CLP, Bauer Munari A, Schneider BF, et al · · 2020 · cited 18× · PMID 32026830 · DOI 10.1016/j.physio.2019.08.007 -
The minimal important difference for Glittre-ADL test in patients with chronic obstructive pulmonary disease.
Gulart AA, Araujo CLP, Munari AB, Santos KD, et al · · 2020 · cited 18× · PMID 30497829 · DOI 10.1016/j.bjpt.2018.11.009
Verify or expand the search:
- PubMed search for NCT03251781
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pulmonary Rehabilitation
Trials testing the same drug.
- NCT07197229 — Hospital- and Home-Based Structured Pulmonary Rehabilitation in Recently Admitted COPD Patients: A Quasi-Experimental St · NA · not yet recruiting
- NCT07376161 — Inflammation and Oxidative Stress in COPD · enrolling by invitation
- NCT07097961 — Paediatric Post-TB Pulmonary Rehab Study · NA · recruiting
- NCT06756230 — Downhill Walking in IPF · NA · recruiting
- NCT06707623 — CPET Guided Rehab vs Physiotherapy in Patients With Dysfunctional Breathing · NA · recruiting
Other recruiting trials for Pulmonary Disease, Chronic Obstructive
Currently open trials in the same condition.
- NCT07177339 — eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (CO · Phase 3 · recruiting
- NCT06961214 — Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and T · Phase 3 · recruiting
- NCT06959095 — Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and T · Phase 3 · recruiting
- NCT06890208 — Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave · recruiting
- NCT06712563 — Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting · recruiting
Other University of the State of Santa Catarina trials
Trials by the same sponsor.
- NCT07469280 — High-Intensity Progressive Inspiratory Muscle Training in Class III Obesity and Obstructive Sleep Apnea · NA · not yet recruiting
- NCT06485063 — Myofascial Reorganization on Performance, and Biomechanical, Viscoelastic, and Thermographic Properties of Athletes · NA · recruiting
- NCT06348186 — Fascial Tissue Response to Manual Therapy: Implications in Long COVID-19 · NA · recruiting
- NCT05760664 — Exercises Directed To Dynamic Stiffness Of The Thoracolumbar Region And Performance Of Amateur Runners · NA · recruiting
- NCT05742542 — The Effects of High vs. Low Time Spent Near VO2max During Two Work-matched High Intensity Interval Training. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03251781 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of the State of Santa Catarina
- Last refreshed: 7 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03251781.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing